Mazda North American Operations
Summary
NHTSA campaign 23V275: Mazda North American Operations recalled for a safety defect. Reduced braking ability can increase the distance required to stop the vehicle, increasing the risk of a crash.
Details
Source
nhtsa
External ID
23V275
Action Date
2023-04-18
Status
Ongoing
Category
vehicle
Product Description
Mazda North American Operations (Mazda) is recalling certain 2022-2023 CX-30 and 2023 CX-50 vehicles. The anti-lock brake system (ABS) Hydraulic Control Unit (HCU) may be damaged, which can result in reduced braking ability.
Context & Analysis
Mazda North American Operations has 25 FDA actions in our database.
Frequently Asked Questions
How often does Mazda North American Operations have FDA actions?
Mazda North American Operations has 25 FDA actions in our database, including 0 recalls and 0 device clearances.
Where can I find the official FDA record?
The official record is available on FDA.gov. Use the link above to view the complete official filing. You can also use the openFDA API to query this record programmatically.
Want to know the moment something like this happens?
Get alerts for vehicle